CLINICAL_TRIALS
withdrawal
· 2014-11-11
Clinical Trial Update: Pilot Study of IV and IP Chemotherapy Plus Abdominal Hyperthermia for Ovarian Ca [NA]
Summary
The trial investigating intravenous and intraperitoneal chemotherapy with abdominal hyperthermia for ovarian cancer has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Mark Dewhirst | Conditions: Ovarian Cancer | NA | Status: WITHDRAWN